drugset / Trial / NCT05519683

Home Transcutaneous Electrical Acustimulation (TEA)

NCT05519683

RandomizedParallel-groupOpen-labelTreatment

Summary

This study will assess the efficacy of two active treatments with TEA and a chemical neuromodulator (escitalopram aka Lexapro) versus a sham comparator or control group on abdominal pain.

Timeline

Start
2022-11-02
Primary completion
2026-09
Completion
2026-09

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Escitalopram Small molecule 10 mg